The global Artificial Pancreas Device System (APDS) market size was valued at USD 73 million in 2023 and is forecast to a readjusted size of USD 158.2 million by 2030 with a CAGR of 11.6% during review period.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
The report includes an overview of the development of the Artificial Pancreas Device System (APDS) industry chain, the market status of Hospitals (Threshold Suspended Device Systems, Hybrid Closed-loop APDS), Clinics (Threshold Suspended Device Systems, Hybrid Closed-loop APDS), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Artificial Pancreas Device System (APDS).
Regionally, the report analyzes the Artificial Pancreas Device System (APDS) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Artificial Pancreas Device System (APDS) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Artificial Pancreas Device System (APDS) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Artificial Pancreas Device System (APDS) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Threshold Suspended Device Systems, Hybrid Closed-loop APDS).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Artificial Pancreas Device System (APDS) market.
Regional Analysis: The report involves examining the Artificial Pancreas Device System (APDS) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Artificial Pancreas Device System (APDS) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Artificial Pancreas Device System (APDS):
Company Analysis: Report covers individual Artificial Pancreas Device System (APDS) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Artificial Pancreas Device System (APDS) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Artificial Pancreas Device System (APDS). It assesses the current state, advancements, and potential future developments in Artificial Pancreas Device System (APDS) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Artificial Pancreas Device System (APDS) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Artificial Pancreas Device System (APDS) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Market segment by Application
Hospitals
Clinics
Market segment by players, this report covers
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Pancreas Device System (APDS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Pancreas Device System (APDS), with revenue, gross margin and global market share of Artificial Pancreas Device System (APDS) from 2019 to 2024.
Chapter 3, the Artificial Pancreas Device System (APDS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Artificial Pancreas Device System (APDS) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Pancreas Device System (APDS).
Chapter 13, to describe Artificial Pancreas Device System (APDS) research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Artificial Pancreas Device System (APDS)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Pancreas Device System (APDS) by Type
1.3.1 Overview: Global Artificial Pancreas Device System (APDS) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Artificial Pancreas Device System (APDS) Consumption Value Market Share by Type in 2023
1.3.3 Threshold Suspended Device Systems
1.3.4 Hybrid Closed-loop APDS
1.3.5 Other Systems
1.4 Global Artificial Pancreas Device System (APDS) Market by Application
1.4.1 Overview: Global Artificial Pancreas Device System (APDS) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.5 Global Artificial Pancreas Device System (APDS) Market Size & Forecast
1.6 Global Artificial Pancreas Device System (APDS) Market Size and Forecast by Region
1.6.1 Global Artificial Pancreas Device System (APDS) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Artificial Pancreas Device System (APDS) Market Size by Region, (2019-2030)
1.6.3 North America Artificial Pancreas Device System (APDS) Market Size and Prospect (2019-2030)
1.6.4 Europe Artificial Pancreas Device System (APDS) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Artificial Pancreas Device System (APDS) Market Size and Prospect (2019-2030)
1.6.6 South America Artificial Pancreas Device System (APDS) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Artificial Pancreas Device System (APDS) Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Artificial Pancreas Device System (APDS) Product and Solutions
2.1.4 Medtronic Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Bigfoot Biomedical
2.2.1 Bigfoot Biomedical Details
2.2.2 Bigfoot Biomedical Major Business
2.2.3 Bigfoot Biomedical Artificial Pancreas Device System (APDS) Product and Solutions
2.2.4 Bigfoot Biomedical Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bigfoot Biomedical Recent Developments and Future Plans
2.3 Beta Bionics
2.3.1 Beta Bionics Details
2.3.2 Beta Bionics Major Business
2.3.3 Beta Bionics Artificial Pancreas Device System (APDS) Product and Solutions
2.3.4 Beta Bionics Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Beta Bionics Recent Developments and Future Plans
2.4 Admetsys
2.4.1 Admetsys Details
2.4.2 Admetsys Major Business
2.4.3 Admetsys Artificial Pancreas Device System (APDS) Product and Solutions
2.4.4 Admetsys Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Admetsys Recent Developments and Future Plans
2.5 Insulet
2.5.1 Insulet Details
2.5.2 Insulet Major Business
2.5.3 Insulet Artificial Pancreas Device System (APDS) Product and Solutions
2.5.4 Insulet Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Insulet Recent Developments and Future Plans
2.6 Tandem Diabetes Care
2.6.1 Tandem Diabetes Care Details
2.6.2 Tandem Diabetes Care Major Business
2.6.3 Tandem Diabetes Care Artificial Pancreas Device System (APDS) Product and Solutions
2.6.4 Tandem Diabetes Care Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Tandem Diabetes Care Recent Developments and Future Plans
2.7 Defymed
2.7.1 Defymed Details
2.7.2 Defymed Major Business
2.7.3 Defymed Artificial Pancreas Device System (APDS) Product and Solutions
2.7.4 Defymed Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Defymed Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Artificial Pancreas Device System (APDS) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Artificial Pancreas Device System (APDS) by Company Revenue
3.2.2 Top 3 Artificial Pancreas Device System (APDS) Players Market Share in 2023
3.2.3 Top 6 Artificial Pancreas Device System (APDS) Players Market Share in 2023
3.3 Artificial Pancreas Device System (APDS) Market: Overall Company Footprint Analysis
3.3.1 Artificial Pancreas Device System (APDS) Market: Region Footprint
3.3.2 Artificial Pancreas Device System (APDS) Market: Company Product Type Footprint
3.3.3 Artificial Pancreas Device System (APDS) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Artificial Pancreas Device System (APDS) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Artificial Pancreas Device System (APDS) Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Artificial Pancreas Device System (APDS) Consumption Value Market Share by Application (2019-2024)
5.2 Global Artificial Pancreas Device System (APDS) Market Forecast by Application (2025-2030)
6 North America
6.1 North America Artificial Pancreas Device System (APDS) Consumption Value by Type (2019-2030)
6.2 North America Artificial Pancreas Device System (APDS) Consumption Value by Application (2019-2030)
6.3 North America Artificial Pancreas Device System (APDS) Market Size by Country
6.3.1 North America Artificial Pancreas Device System (APDS) Consumption Value by Country (2019-2030)
6.3.2 United States Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
6.3.3 Canada Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
6.3.4 Mexico Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Artificial Pancreas Device System (APDS) Consumption Value by Type (2019-2030)
7.2 Europe Artificial Pancreas Device System (APDS) Consumption Value by Application (2019-2030)
7.3 Europe Artificial Pancreas Device System (APDS) Market Size by Country
7.3.1 Europe Artificial Pancreas Device System (APDS) Consumption Value by Country (2019-2030)
7.3.2 Germany Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
7.3.3 France Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
7.3.5 Russia Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
7.3.6 Italy Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Artificial Pancreas Device System (APDS) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Artificial Pancreas Device System (APDS) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Artificial Pancreas Device System (APDS) Market Size by Region
8.3.1 Asia-Pacific Artificial Pancreas Device System (APDS) Consumption Value by Region (2019-2030)
8.3.2 China Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
8.3.3 Japan Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
8.3.4 South Korea Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
8.3.5 India Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
8.3.7 Australia Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
9 South America
9.1 South America Artificial Pancreas Device System (APDS) Consumption Value by Type (2019-2030)
9.2 South America Artificial Pancreas Device System (APDS) Consumption Value by Application (2019-2030)
9.3 South America Artificial Pancreas Device System (APDS) Market Size by Country
9.3.1 South America Artificial Pancreas Device System (APDS) Consumption Value by Country (2019-2030)
9.3.2 Brazil Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
9.3.3 Argentina Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Artificial Pancreas Device System (APDS) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Artificial Pancreas Device System (APDS) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Artificial Pancreas Device System (APDS) Market Size by Country
10.3.1 Middle East & Africa Artificial Pancreas Device System (APDS) Consumption Value by Country (2019-2030)
10.3.2 Turkey Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
10.3.4 UAE Artificial Pancreas Device System (APDS) Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Artificial Pancreas Device System (APDS) Market Drivers
11.2 Artificial Pancreas Device System (APDS) Market Restraints
11.3 Artificial Pancreas Device System (APDS) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Artificial Pancreas Device System (APDS) Industry Chain
12.2 Artificial Pancreas Device System (APDS) Upstream Analysis
12.3 Artificial Pancreas Device System (APDS) Midstream Analysis
12.4 Artificial Pancreas Device System (APDS) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
听
听
*If Applicable.
